2014
DOI: 10.1016/j.rcl.2014.02.010
|View full text |Cite
|
Sign up to set email alerts
|

MR Imaging of the Prostate

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
23
0

Year Published

2014
2014
2017
2017

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 30 publications
(23 citation statements)
references
References 146 publications
0
23
0
Order By: Relevance
“…Excluded (n = 23) Withdrawn consent (8) No surgery was performed Skeletal metastases on MRI (4) Referred to radiation therapy (1) Cancelled surgery (9) Underwent surgery in another country (1) …”
Section: Enrolmentmentioning
confidence: 99%
See 1 more Smart Citation
“…Excluded (n = 23) Withdrawn consent (8) No surgery was performed Skeletal metastases on MRI (4) Referred to radiation therapy (1) Cancelled surgery (9) Underwent surgery in another country (1) …”
Section: Enrolmentmentioning
confidence: 99%
“…When present, the secondary and tertiary tumour is the two next highest ranking tumours according to the same criteria. The sensitivity of MRI for predicting T3 is limited, ranging from 13% to 95%, depending on patient selection and the method used [8,9]. The laterality of T3 is rarely reported, although it is highly relevant when planning treatment [5,10].…”
Section: Introductionmentioning
confidence: 99%
“…There are only case reports available in the literature concerning the integration of an adequate multiparametric protocol for prostate cancer evaluation. [66][67][68] The advent of 68 galliumlabeled ligand of the prostate-specific membrane antigen has the potential to improve prostate cancer evaluation in cases where even advanced MRI protocols fail to detect early cancer deposits. 69…”
Section: Advanced Protocolmentioning
confidence: 99%
“…Limitations when locally staging prostate cancer for treatment planning purposes include: low specificity, missed regions of the prostate during DRE or biopsy (e.g., anterior tumours), and potentially inaccurate information regarding tumour volume, extent and aggressiveness of disease with DRE and non-targeted TRUS-guided biopsy. 2 There is renewed interest in the benefits of magnetic resonance imaging (MRI) (± functional sequences) in the local staging of prostate cancer. T2-weighted MRI for local staging of prostate cancer traditionally involves high-resolution imaging, which delineates the prostatic anatomy in detail.…”
Section: Introductionmentioning
confidence: 99%